Aptevo Therapeutics Inc.APVONASDAQ
Loading
Year-over-year total asset growth rate
5Y CAGR
-6.6%/yr
Long-term compound
Percentile
P95
Near historical high
vs 5Y Ago
0.7x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 72.79% |
| Q2 2025 | 87.29% |
| Q1 2025 | -46.49% |
| Q4 2024 | 2.94% |
| Q3 2024 | 1.51% |
| Q2 2024 | -15.36% |
| Q1 2024 | -29.04% |
| Q4 2023 | -8.43% |
| Q3 2023 | -6.17% |
| Q2 2023 | -17.32% |
| Q1 2023 | 2.20% |
| Q4 2022 | 7.95% |
| Q3 2022 | -18.31% |
| Q2 2022 | -14.13% |
| Q1 2022 | -20.17% |
| Q4 2021 | -11.57% |
| Q3 2021 | -10.45% |
| Q2 2021 | 3.96% |
| Q1 2021 | 28.40% |
| Q4 2020 | 43.10% |
| Q3 2020 | 102.17% |
| Q2 2020 | -26.68% |
| Q1 2020 | -52.73% |
| Q4 2019 | -11.80% |
| Q3 2019 | -8.42% |
| Q2 2019 | -18.20% |
| Q1 2019 | 19.78% |
| Q4 2018 | -14.49% |
| Q3 2018 | -12.29% |
| Q2 2018 | -10.19% |
| Q1 2018 | -14.35% |
| Q4 2017 | -10.70% |
| Q3 2017 | 50.79% |
| Q2 2017 | -11.15% |
| Q1 2017 | 6.46% |
| Q4 2016 | -8.71% |
| Q3 2016 | -14.84% |
| Q2 2016 | -16.55% |
| Q1 2016 | 25.91% |
| Q4 2015 | 0.00% |